Improving the stability of cultured red blood cells during storage.

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-08-19 DOI:10.1111/vox.70095
Christian J Stevens-Hernandez, Sabine Kupzig, Paraskevi Diamanti, Nicola M Cogan, Allison Blair, Lesley J Bruce
{"title":"Improving the stability of cultured red blood cells during storage.","authors":"Christian J Stevens-Hernandez, Sabine Kupzig, Paraskevi Diamanti, Nicola M Cogan, Allison Blair, Lesley J Bruce","doi":"10.1111/vox.70095","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Cultured red blood cells (cRBCs) have many potential applications, including in diagnostics, as drug delivery carriers or for specialized clinical use. However, cRBCs are immature reticulocytes that do not store well. After 10 days of cold storage in saline, adenine, glucose, mannitol (SAG-M), cRBCs show around 8% haemolysis compared to <0.8% for mature RBCs. This study aimed to develop a better storage medium to enhance cRBC stability and viability.</p><p><strong>Materials and methods: </strong>cRBCs were cultured from CD34<sup>+</sup> haemopoietic cells from peripheral blood and resuspended at 1.5 × 10<sup>9</sup>/mL in SAG-M or SAG-M with different macromolecules (10% human serum albumin, 10% Dextran-40, 10% Ficoll-70). The effect of rejuvenation before storage was also investigated. Haemolysis and morphology assessment were carried out on Days 10, 16 and 20 of storage at 4°C. In vivo assays were performed by injecting 2 × 10<sup>8</sup> cRBCs into NOD.Cg-Prkdc<sup>scid</sup>Il2rγ<sup>tm1Wjl</sup>/SzJ mice on Days 1, 9 and 21 of storage. Clearance and maturation of cRBCs were assessed at different intervals post injection.</p><p><strong>Results: </strong>Addition of macromolecules significantly improved cRBC stability; 10% Dextran-40 reduced haemolysis of cRBCs to <2% over 20 days of cold storage. Rejuvenation had no significant effect. Similar numbers, morphology and maturation of cRBCs were detected in the murine circulation, whether or not stored in SAG-M or SAG-M + 10% Dx-40, regardless of storage time.</p><p><strong>Conclusion: </strong>Addition of macromolecules to SAG-M improves cRBCs storage stability and does not affect their clearance or maturation in the in vivo model. To our knowledge, this is the first report showing evidence of improved stability of cRBCs during storage.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70095","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Cultured red blood cells (cRBCs) have many potential applications, including in diagnostics, as drug delivery carriers or for specialized clinical use. However, cRBCs are immature reticulocytes that do not store well. After 10 days of cold storage in saline, adenine, glucose, mannitol (SAG-M), cRBCs show around 8% haemolysis compared to <0.8% for mature RBCs. This study aimed to develop a better storage medium to enhance cRBC stability and viability.

Materials and methods: cRBCs were cultured from CD34+ haemopoietic cells from peripheral blood and resuspended at 1.5 × 109/mL in SAG-M or SAG-M with different macromolecules (10% human serum albumin, 10% Dextran-40, 10% Ficoll-70). The effect of rejuvenation before storage was also investigated. Haemolysis and morphology assessment were carried out on Days 10, 16 and 20 of storage at 4°C. In vivo assays were performed by injecting 2 × 108 cRBCs into NOD.Cg-PrkdcscidIl2rγtm1Wjl/SzJ mice on Days 1, 9 and 21 of storage. Clearance and maturation of cRBCs were assessed at different intervals post injection.

Results: Addition of macromolecules significantly improved cRBC stability; 10% Dextran-40 reduced haemolysis of cRBCs to <2% over 20 days of cold storage. Rejuvenation had no significant effect. Similar numbers, morphology and maturation of cRBCs were detected in the murine circulation, whether or not stored in SAG-M or SAG-M + 10% Dx-40, regardless of storage time.

Conclusion: Addition of macromolecules to SAG-M improves cRBCs storage stability and does not affect their clearance or maturation in the in vivo model. To our knowledge, this is the first report showing evidence of improved stability of cRBCs during storage.

提高培养红细胞在贮藏过程中的稳定性。
背景和目的:培养红细胞(crbc)有许多潜在的应用,包括在诊断中,作为药物输送载体或专门的临床应用。然而,红细胞是不成熟的网状细胞,不能很好地储存。在生理盐水、腺苷、葡萄糖、甘露醇(SAG-M)中冷藏10天后,crbc的溶血率约为8%。材料和方法:从外周血CD34+造血细胞中培养crbc,并以1.5 × 109/mL的浓度在含有不同大分子(10%人血清白蛋白、10%葡聚糖-40、10% Ficoll-70)的SAG-M或SAG-M中重悬。并对贮藏前返老还童的效果进行了研究。在4°C保存的第10、16和20天进行溶血和形态评估。通过向NOD中注射2 × 108个crbc进行体内检测。g- prkdcscidil2r γ tm1wjl /SzJ小鼠在第1,9和21天的储存。在注射后的不同时间间隔评估红细胞的清除率和成熟度。结果:大分子的加入显著提高了cRBC的稳定性;结论:在体内模型中,向SAG-M中添加大分子可提高红细胞的储存稳定性,且不影响其清除或成熟。据我们所知,这是第一份显示红细胞在储存期间稳定性提高的证据的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信